Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Characterization of drug release from fibrin gels loaded with different pharmaceutical and experimental doxorubicin formulations.

Viale M, Monticone M, Maric I, Giglio V, Profumo A, Aprile A, Cilli M, Abelmoschi ML, Rocco M.

Pharmacol Rep. 2018 Feb 21;70(4):760-765. doi: 10.1016/j.pharep.2018.02.014. [Epub ahead of print]

PMID:
29936363
2.

CHL1 gene acts as a tumor suppressor in human neuroblastoma.

Ognibene M, Pagnan G, Marimpietri D, Cangelosi D, Cilli M, Benedetti MC, Boldrini R, Garaventa A, Frassoni F, Eva A, Varesio L, Pistoia V, Pezzolo A.

Oncotarget. 2018 May 25;9(40):25903-25921. doi: 10.18632/oncotarget.25403. eCollection 2018 May 25.

3.

REDUCTION OF ARRHYTHMIAS IN PRIMARY HYPERPARATHYROIDISM, BY PARATHYROIDECTOMY, EVALUATED WITH 24 HOUR ECG MONITORING.

Pepe J, Cipriani C, Curione M, Biamonte F, Colangelo L, Danese V, Cecchetti V, Sonato C, Ferrone F, Cilli M, Minisola S.

Eur J Endocrinol. 2018 Jun 6. pii: EJE-17-0948. doi: 10.1530/EJE-17-0948. [Epub ahead of print]

PMID:
29875287
4.

A Challenging Case of Tumor-Induced Osteomalacia: Pathophysiological and Clinical Implications.

Colangelo L, Cipriani C, Pepe J, Corsi A, Sonato C, Follacchio G, Cilli M, Gianni W, Ferrone F, Moreschini O, Fitzpatrick LA, Minisola S.

Calcif Tissue Int. 2018 May 7. doi: 10.1007/s00223-018-0429-x. [Epub ahead of print]

PMID:
29736882
5.

A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy.

Sidarovich V, De Mariano M, Aveic S, Pancher M, Adami V, Gatto P, Pizzini S, Pasini L, Croce M, Parodi F, Cimmino F, Avitabile M, Emionite L, Cilli M, Ferrini S, Pagano A, Capasso M, Quattrone A, Tonini GP, Longo L.

Mol Cancer Ther. 2018 Jul;17(7):1405-1415. doi: 10.1158/1535-7163.MCT-17-0841. Epub 2018 Apr 25.

PMID:
29695637
6.

Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence.

Cutrona G, Tripodo C, Matis S, Recchia AG, Massucco C, Fabbi M, Colombo M, Emionite L, Sangaletti S, Gulino A, Reverberi D, Massara R, Boccardo S, de Totero D, Salvi S, Cilli M, Pellicanò M, Manzoni M, Fabris S, Airoldi I, Valdora F, Ferrini S, Gentile M, Vigna E, Bossio S, De Stefano L, Palummo A, Iaquinta G, Cardillo M, Zupo S, Cerruti G, Ibatici A, Neri A, Fais F, Ferrarini M, Morabito F.

Sci Transl Med. 2018 Feb 14;10(428). pii: eaal1571. doi: 10.1126/scitranslmed.aal1571.

PMID:
29444977
7.

Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model.

Bocca P, Di Carlo E, Caruana I, Emionite L, Cilli M, De Angelis B, Quintarelli C, Pezzolo A, Raffaghello L, Morandi F, Locatelli F, Pistoia V, Prigione I.

Oncoimmunology. 2017 Oct 4;7(1):e1378843. doi: 10.1080/2162402X.2017.1378843. eCollection 2017.

PMID:
29296542
8.

Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL Pathway.

Marini C, Bruno S, Fiz F, Campi C, Piva R, Cutrona G, Matis S, Nieri A, Miglino M, Ibatici A, Maria Orengo A, Maria Massone A, Neumaier CE, Totero D, Giannoni P, Bauckneht M, Pennone M, Tenca C, Gugiatti E, Bellini A, Borra A, Tedone E, Efetürk H, Rosa F, Emionite L, Cilli M, Bagnara D, Brucato V, Bruzzi P, Piana M, Fais F, Sambuceti G.

Sci Rep. 2017 Oct 26;7(1):14159. doi: 10.1038/s41598-017-12761-1.

9.

Mineral metabolism abnormalities in patients with prostate cancer: a systematic case controlled study.

Minisola F, Cipriani C, Colangelo L, Cilli M, Sciarra A, Von Heland M, Nieddu L, Anastasi E, Pascone R, Fassino V, Diacinti D, Longo F, Minisola S, Pepe J.

Endocrine. 2018 Feb;59(2):338-343. doi: 10.1007/s12020-017-1351-0. Epub 2017 Jun 28.

PMID:
28660378
10.

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.

Cutrona G, Matis S, Colombo M, Massucco C, Baio G, Valdora F, Emionite L, Fabris S, Recchia AG, Gentile M, Neumaier CE, Reverberi D, Massara R, Boccardo S, Basso L, Salvi S, Rosa F, Cilli M, Zupo S, Truini M, Tassone P, Calabrese M, Negrini M, Neri A, Morabito F, Fais F, Ferrarini M.

Leukemia. 2017 Sep;31(9):1894-1904. doi: 10.1038/leu.2016.394. Epub 2017 Jan 5.

PMID:
28053325
11.

Adipokines and bone metabolism: an interplay to untangle.

Pepe J, Cipriani C, Cilli M, Colangelo L, Minisola S.

J Endocrinol Invest. 2016 Nov;39(11):1359-1361. Epub 2016 Sep 17. No abstract available.

PMID:
27639402
12.

A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo.

Amaro A, Angelini G, Mirisola V, Esposito AI, Reverberi D, Matis S, Maffei M, Giaretti W, Viale M, Gangemi R, Emionite L, Astigiano S, Cilli M, Bachmeier BE, Killian PH, Albini A, Pfeffer U.

Oncotarget. 2016 Oct 18;7(42):68803-68820. doi: 10.18632/oncotarget.11931.

13.

A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).

Valdora F, Cutrona G, Matis S, Morabito F, Massucco C, Emionite L, Boccardo S, Basso L, Recchia AG, Salvi S, Rosa F, Gentile M, Ravina M, Pace D, Castronovo A, Cilli M, Truini M, Calabrese M, Neri A, Neumaier CE, Fais F, Baio G, Ferrarini M.

Clin Immunol. 2016 Nov;172:52-60. doi: 10.1016/j.clim.2016.07.013. Epub 2016 Jul 16.

14.

Characterization of a Polymer-Based, Fully Organic Prosthesis for Implantation into the Subretinal Space of the Rat.

Antognazza MR, Di Paolo M, Ghezzi D, Mete M, Di Marco S, Maya-Vetencourt JF, Maccarone R, Desii A, Di Fonzo F, Bramini M, Russo A, Laudato L, Donelli I, Cilli M, Freddi G, Pertile G, Lanzani G, Bisti S, Benfenati F.

Adv Healthc Mater. 2016 Sep;5(17):2271-82. doi: 10.1002/adhm.201600318. Epub 2016 May 30.

PMID:
27240295
15.

High prevalence of abdominal aortic calcification in patients with primary hyperparathyroidism as evaluated by Kauppila score.

Pepe J, Diacinti D, Fratini E, Nofroni I, D'Angelo A, Pilotto R, Savoriti C, Colangelo L, Raimo O, Cilli M, Cipriani C, Minisola S.

Eur J Endocrinol. 2016 Aug;175(2):95-100. doi: 10.1530/EJE-15-1152. Epub 2016 May 10.

16.

Update on vitamin D: pros and cons.

Cipriani C, Piemonte S, Cilli M, Pepe J, Minisola S.

Clin Cases Miner Bone Metab. 2015 Sep-Dec;12(3):222-3. doi: 10.11138/ccmbm/2015.12.3.222. Epub 2015 Dec 29. Review.

17.

Identification of a New Cell Population Constitutively Circulating in Healthy Conditions and Endowed with a Homing Ability Toward Injured Sites.

Lo Sicco C, Tasso R, Reverberi D, Cilli M, Pfeffer U, Cancedda R.

Sci Rep. 2015 Nov 12;5:16574. doi: 10.1038/srep16574.

18.

Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model.

Viale M, Rossi M, Russo E, Cilli M, Aprile A, Profumo A, Santi P, Fenoglio C, Cafaggi S, Rocco M.

Invest New Drugs. 2015 Dec;33(6):1151-61. doi: 10.1007/s10637-015-0291-x. Epub 2015 Oct 7.

PMID:
26445859
19.

A reappraisal of vitamin D effect on non-skeletal targets and mortality.

Minisola S, Cipriani C, Cilli M, Scillitani A, Pepe J.

J Endocrinol Invest. 2015 Nov;38(11):1239-41. doi: 10.1007/s40618-015-0387-3. Epub 2015 Sep 10. Review. No abstract available.

PMID:
26359144
20.

New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.

Di Paolo D, Yang D, Pastorino F, Emionite L, Cilli M, Daga A, Destafanis E, Di Fiore A, Piaggio F, Brignole C, Xu X, Liang C, Gibbons J, Ponzoni M, Perri P.

Oncotarget. 2015 Oct 6;6(30):28774-89. doi: 10.18632/oncotarget.4342.

21.

The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.

Bartolini A, Di Paolo D, Noghero A, Murgia D, Sementa AR, Cilli M, Pasqualini R, Arap W, Bussolino F, Ponzoni M, Pastorino F, Marchiò S.

Cancer Res. 2015 Oct 15;75(20):4265-71. doi: 10.1158/0008-5472.CAN-15-0649. Epub 2015 Aug 20.

22.

Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion.

Cossu I, Bottoni G, Loi M, Emionite L, Bartolini A, Di Paolo D, Brignole C, Piaggio F, Perri P, Sacchi A, Curnis F, Gagliani MC, Bruno S, Marini C, Gori A, Longhi R, Murgia D, Sementa AR, Cilli M, Tacchetti C, Corti A, Sambuceti G, Marchiò S, Ponzoni M, Pastorino F.

Biomaterials. 2015 Nov;68:89-99. doi: 10.1016/j.biomaterials.2015.07.054. Epub 2015 Aug 1.

23.

An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study.

Pepe J, Mezzaroma I, Fantauzzi A, Falciano M, Salotti A, Di Traglia M, Diacinti D, Biondi P, Cipriani C, Cilli M, Minisola S.

Endocrine. 2016 Jul;53(1):299-304. doi: 10.1007/s12020-015-0693-8. Epub 2015 Aug 9.

PMID:
26254790
24.

Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells.

Manente AG, Pinton G, Zonca S, Cilli M, Rinaldi M, Daga A, Nilsson S, Moro L.

Oncotarget. 2015 Sep 22;6(28):25121-34. doi: 10.18632/oncotarget.4486.

25.

Effects of long time exposure to simulated micro- and hypergravity on skeletal architecture.

Canciani B, Ruggiu A, Giuliani A, Panetta D, Marozzi K, Tripodi M, Salvadori PA, Cilli M, Ohira Y, Cancedda R, Tavella S.

J Mech Behav Biomed Mater. 2015 Nov;51:1-12. doi: 10.1016/j.jmbbm.2015.06.014. Epub 2015 Jun 23.

PMID:
26188564
26.

Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation.

Tomati V, Sondo E, Armirotti A, Caci E, Pesce E, Marini M, Gianotti A, Jeon YJ, Cilli M, Pistorio A, Mastracci L, Ravazzolo R, Scholte B, Ronai Z, Galietta LJ, Pedemonte N.

Sci Rep. 2015 Jul 17;5:12138. doi: 10.1038/srep12138.

27.

Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.

Zuccari G, Milelli A, Pastorino F, Loi M, Petretto A, Parise A, Marchetti C, Minarini A, Cilli M, Emionite L, Di Paolo D, Brignole C, Piaggio F, Perri P, Tumiatti V, Pistoia V, Pagnan G, Ponzoni M.

J Control Release. 2015 Aug 10;211:44-52. doi: 10.1016/j.jconrel.2015.05.286. Epub 2015 May 29.

PMID:
26031842
28.

Biomechanical effects of daily physical activities on the lower limb.

Serbest K, Çilli M, Eldoğan O.

Acta Orthop Traumatol Turc. 2015;49(1):85-90. doi: 10.3944/AOTT.2015.3180.

29.

Acute effects of a resisted dynamic warm-up protocol on jumping performance.

Cilli M, Gelen E, Yildiz S, Saglam T, Camur M.

Biol Sport. 2014 Dec;31(4):277-82. doi: 10.5604/20831862.1120935. Epub 2014 Sep 12.

30.

Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.

Pezzolo A, Marimpietri D, Raffaghello L, Cocco C, Pistorio A, Gambini C, Cilli M, Horenstein A, Malavasi F, Pistoia V.

Oncotarget. 2014 Nov 15;5(21):10368-81.

31.

Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity.

Pinton G, Manente AG, Daga A, Cilli M, Rinaldi M, Nilsson S, Moro L.

Mol Cancer. 2014 Oct 2;13:227. doi: 10.1186/1476-4598-13-227.

32.

Emerging data on cardiovascular risk in primary hyperparathyroidism.

Pepe J, Piemonte S, Cipriani C, Cilli M, Minisola S.

Endocrine. 2014 Nov;47(2):345-7. doi: 10.1007/s12020-014-0415-7. Epub 2014 Sep 10. No abstract available.

PMID:
25205449
33.

Vitamin d and its relationship with obesity and muscle.

Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S.

Int J Endocrinol. 2014;2014:841248. doi: 10.1155/2014/841248. Epub 2014 Aug 5. Review.

34.

sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib.

Loi M, Becherini P, Emionite L, Giacomini A, Cossu I, Destefanis E, Brignole C, Di Paolo D, Piaggio F, Perri P, Cilli M, Pastorino F, Ponzoni M.

J Control Release. 2014 Oct 28;192:157-66. doi: 10.1016/j.jconrel.2014.07.009. Epub 2014 Jul 17.

PMID:
25041999
35.

Effects of benzodiazepine on neuromuscular activity performance in archers.

Ergen E, Açikada C, Hazir T, Güner R, Çilli M, Ergün Acar Y.

J Sports Med Phys Fitness. 2015 Sep;55(9):995-1003. Epub 2014 Jul 7.

PMID:
24998614
36.

Quality of life in patients with primary hyperparathyroidism.

Cipriani C, Romagnoli E, Cilli M, Piemonte S, Pepe J, Minisola S.

Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):113-21. doi: 10.1586/14737167.2014.873702. Epub 2014 Jan 7. Review.

PMID:
24397607
37.

Semitendinosus snapping: analysis of movement, electromyographic activities, muscle strength and endurance, motor control and joint position sense.

Guney H, Kaya D, Yilgor C, Cilli M, Aritan S, Yuksel I, Doral MN.

Muscles Ligaments Tendons J. 2013 Aug 11;3(3):166-72. eCollection 2013 Jul.

38.

Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer.

Marini C, Salani B, Massollo M, Amaro A, Esposito AI, Orengo AM, Capitanio S, Emionite L, Riondato M, Bottoni G, Massara C, Boccardo S, Fabbi M, Campi C, Ravera S, Angelini G, Morbelli S, Cilli M, Cordera R, Truini M, Maggi D, Pfeffer U, Sambuceti G.

Cell Cycle. 2013 Nov 15;12(22):3490-9. doi: 10.4161/cc.26461.

39.

Effect of a single oral dose of 600,000 IU of cholecalciferol on muscle strength: a study in young women.

Cipriani C, Romagnoli E, Carnevale V, Clerico R, Pepe J, Cilli M, Diacinti D, Savoriti C, Colangelo L, Minisola S.

J Endocrinol Invest. 2013 Dec;36(11):1051-4. doi: 10.3275/9062. Epub 2013 Jul 23.

PMID:
23888368
40.

Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature.

D'Amico L, Patanè S, Grange C, Bussolati B, Isella C, Fontani L, Godio L, Cilli M, D'Amelio P, Isaia G, Medico E, Ferracini R, Roato I.

Br J Cancer. 2013 Jun 25;108(12):2525-36. doi: 10.1038/bjc.2013.271.

41.

Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.

Di Paolo D, Pastorino F, Zuccari G, Caffa I, Loi M, Marimpietri D, Brignole C, Perri P, Cilli M, Nico B, Ribatti D, Pistoia V, Ponzoni M, Pagnan G.

J Control Release. 2013 Sep 28;170(3):445-51. doi: 10.1016/j.jconrel.2013.06.015. Epub 2013 Jun 19.

PMID:
23792118
42.

Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test.

Pepe J, Curione M, Morelli S, Varrenti M, Cammarota C, Cilli M, Piemonte S, Cipriani C, Savoriti C, Raimo O, De Lucia F, Colangelo L, Clementelli C, Romagnoli E, Minisola S.

Eur J Endocrinol. 2013 Jul 13;169(2):255-61. doi: 10.1530/EJE-13-0293. Print 2013 Aug.

43.

Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.

Loi M, Di Paolo D, Soster M, Brignole C, Bartolini A, Emionite L, Sun J, Becherini P, Curnis F, Petretto A, Sani M, Gori A, Milanese M, Gambini C, Longhi R, Cilli M, Allen TM, Bussolino F, Arap W, Pasqualini R, Corti A, Ponzoni M, Marchiò S, Pastorino F.

J Control Release. 2013 Sep 10;170(2):233-41. doi: 10.1016/j.jconrel.2013.04.029. Epub 2013 May 25.

44.

The effect of parathyroidectomy on chronic constipation in patients affected by primary hyperparathyroidism.

Pepe J, Badiali D, Biviano I, Nofroni I, Romagnoli E, Cilli M, Piemonte S, Cipriani C, Colangelo L, Minisola S.

J Bone Miner Metab. 2013 Nov;31(6):690-4. doi: 10.1007/s00774-013-0453-x. Epub 2013 Apr 6.

PMID:
23563978
45.

Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.

Di Carlo E, Bocca P, Emionite L, Cilli M, Cipollone G, Morandi F, Raffaghello L, Pistoia V, Prigione I.

Mol Ther. 2013 May;21(5):1034-43. doi: 10.1038/mt.2013.38. Epub 2013 Mar 12.

46.

Intermittent high doses of vitamin D: a need for further studies?

Minisola S, Colangelo L, Cilli M, Cipriani C, Pepe J, Romagnoli E.

Calcif Tissue Int. 2013 May;92(5):487-8. doi: 10.1007/s00223-013-9714-x. Epub 2013 Feb 26. No abstract available.

PMID:
23435573
47.

Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice.

Massollo M, Marini C, Brignone M, Emionite L, Salani B, Riondato M, Capitanio S, Fiz F, Democrito A, Amaro A, Morbelli S, Piana M, Maggi D, Cilli M, Pfeffer U, Sambuceti G.

J Nucl Med. 2013 Feb;54(2):259-66. doi: 10.2967/jnumed.112.106666. Epub 2013 Jan 3.

48.

Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition.

Bianchi G, Morandi F, Cilli M, Daga A, Bocelli-Tyndall C, Gambini C, Pistoia V, Raffaghello L.

PLoS One. 2012;7(10):e48654. doi: 10.1371/journal.pone.0048654. Epub 2012 Oct 31.

49.

Evaluation of compliance to telehomecare (THC) in a group of patients with cystic fibrosis (CF) in a period of 2 years.

Murgia F, Cotognini C, Montemitro E, Cilli M, Renzetti E, Lucidi V, Bella S.

Clin Ter. 2012;163(3):e111-4.

PMID:
22964701
50.

Role of dopaminergic receptors in the human dura mater in the pathogenesis of headache.

Tonnarini G, Gianturco V, Cilli M, Minisola S, Cavallotti C.

Clin Ter. 2012;163(3):e101-6.

PMID:
22964699

Supplemental Content

Support Center